Alex Dodoo
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 6
-
- Pharmaceutical Quality and Counterfeiting 2
- Co-authors
- Sten Olsson (2 shared papers)Shanthi Pal (2 shared papers)Hannes Enlund (1 shared paper)Lloyd Matowe (1 shared paper)Mahama Duwiejua (1 shared paper)Patrick Imbert (1 shared paper)Olivier Bouchaud (1 shared paper)Martin Danis (1 shared paper)
- Journals
- Malaria Journal (3 papers)Frontiers in Pharmacology (1 paper)Expert Opinion on Drug Safety (1 paper)Drug Safety (1 paper)Globalization and Health (1 paper)
- Partner nations
- GhanaSwitzerlandUnited States
In The Last Decade
Alex Dodoo
14 papers receiving 407 citations
Peers
Comparison fields: 5 of 82
- Toxicology 145
- Health 60
- Applied Microbiology and Biotechnology 9
- Geriatrics and Gerontology 15
- Public Health, Environmental and Occupational Health 109
Countries citing papers authored by Alex Dodoo
This map shows the geographic impact of Alex Dodoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Dodoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Dodoo more than expected).
Fields of papers citing papers by Alex Dodoo
This network shows the impact of papers produced by Alex Dodoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Dodoo. The network helps show where Alex Dodoo may publish in the future.
Co-authors
The 25 scholars most cited alongside Alex Dodoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 116 | |
| 2 | 2004 | 62 | |
| 3 | 2009 | 53 | |
| 4 | 2007 | 52 | |
| 5 | 2011 | 31 | |
| 6 | 2018 | 30 | |
| 7 | 2019 | 25 | |
| 8 | 2008 | 18 | |
| 9 | 2011 | 16 | |
| 10 | 2015 | 11 | |
| 11 | 2015 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 4 | |
| 14 | 2007 | 1 |
About Alex Dodoo
Alex Dodoo is a scholar working on Toxicology, Public Health, Environmental and Occupational Health, Economics and Econometrics, Infectious Diseases and Health, having authored 14 papers that have together received 434 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Vaccine Coverage and Hesitancy (2 papers), Pharmaceutical Quality and Counterfeiting (2 papers), Pharmaceutical Economics and Policy (2 papers), Sustainable Building Design and Assessment (1 paper), Tuberculosis Research and Epidemiology (1 paper), Virology and Viral Diseases (1 paper) and Recycled Aggregate Concrete Performance (1 paper). The work is most often cited by research in Toxicology (145 citations), Health (60 citations), Applied Microbiology and Biotechnology (9 citations), Geriatrics and Gerontology (15 citations) and Public Health, Environmental and Occupational Health (109 citations). Alex Dodoo has collaborated with scholars based in Ghana, Switzerland and United States. Frequent co-authors include Sten Olsson, Shanthi Pal, Hannes Enlund, Lloyd Matowe, Mahama Duwiejua, Patrick Imbert, Olivier Bouchaud, Martin Danis, Fabrice Legros and Daniel Arhinful. Their work appears in journals such as Malaria Journal, Frontiers in Pharmacology, Expert Opinion on Drug Safety, Drug Safety and Globalization and Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.